Trial intelligence / Profile preview

IL-2 Addition in HIV-HCV Coinfected Non-Responders

NCT00196586Phase 2Completed

Sponsor
ANRS
Start
Apr 2003
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of aldesleukin in chronic hepatitis C (CHC), sponsored by ANRS. Started Apr 2003; status: completed.

02

Drugs

aldesleukin
03

Conditions

chronic hepatitis C (CHC)

Beyond the preview

Go deeper on NCT00196586.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00196586.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call